Numerai GP LLC Has $523,000 Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Numerai GP LLC lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 50.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,547 shares of the medical instruments supplier's stock after selling 28,496 shares during the quarter. Numerai GP LLC's holdings in DENTSPLY SIRONA were worth $523,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC lifted its stake in DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after purchasing an additional 54,920 shares during the period. Pallas Capital Advisors LLC bought a new position in DENTSPLY SIRONA in the 4th quarter valued at about $264,000. Oak Thistle LLC lifted its position in shares of DENTSPLY SIRONA by 93.2% during the 4th quarter. Oak Thistle LLC now owns 31,590 shares of the medical instruments supplier's stock valued at $600,000 after acquiring an additional 15,240 shares during the period. First Community Trust NA acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $163,000. Finally, UMB Bank n.a. boosted its stake in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. The trade was a 22.66% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.50% of the stock is owned by insiders.

DENTSPLY SIRONA Trading Up 1.1%

XRAY traded up $0.19 during mid-day trading on Tuesday, hitting $16.82. 351,822 shares of the stock were exchanged, compared to its average volume of 2,955,108. The company has a market cap of $3.35 billion, a PE ratio of -8.12, a PEG ratio of 1.80 and a beta of 0.92. The firm's fifty day moving average is $14.43 and its two-hundred day moving average is $17.25. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $28.44. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company's revenue for the quarter was down 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.42 EPS. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.81%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.10%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price objective for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Finally, Barrington Research boosted their price objective on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a report on Monday, May 12th. Eleven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.